Phan Thi Kim Phung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Phan Thi Kim Phung has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Duc-Tuan Nguyen
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 41-43 Đinh Tien Hoang, Saigon Ward, Ho Chi Minh City 700000, Vietnam
1 shared publication - Hoang-Han Do
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam
1 shared publication - Kien Duc Ngo
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam
1 shared publication - Manh Dung Doan
Institute of Biotechnology and Environment, Tay Nguyen University, Buon Ma Thuot, Vietnam
1 shared publication - Manh Hung Tran
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam
1 shared publication - Minh-Quan Le
School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam
1 shared publication
Latest Publications
- 9 April 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (14)
Enrichment of Vitexin and Isovitexin From Santalum album L. Leaves and Evaluation of Their In Vitro and In Vivo Biological Activities
Vitexin and isovitexin are flavonoids with diverse pharmacological properties; however, their enrichment usually relies on chromatographic techniques, which are labor‐intensive and costly. This study reports, for the first time, a simple and chromatography‐free method to prepare a vitexin‐ and isovitexin‐enriched extract (VIEE) from Santalum album L. leaves. The method involved (i) biphasic partitioning between n‐hexane and water, followed by (ii) cold‐water recrystallization. UHPLC analysis confirmed that VIEE contained 456.038 mg/g vitexin and 221.422 mg/g isovitexin (67.75% total), corresponding to a 6.1‐fold increase compared with the hydroethanolic extract. Toxicological assessment demonstrated high safety, with LD 50 > 2.5 g/kg and no adverse effects in a 28‐day sub‐acute study at doses up to 900 mg/kg. Biologically, VIEE exhibited moderate inhibition of α‐glucosidase and α‐amylase , potent antioxidant activity in DPPH and ABTS assays, and acetylcholinesterase inhibition comparable to berberine. In streptozotocin‐induced diabetic mice, VIEE (300 mg/kg) lowered blood glucose by 43.2% after 14 days, prevented weight loss, and showed efficacy comparable to glibenclamide (47.9% reduction), while not affecting normoglycemic mice. Overall, this study introduces a cost‐effective, scalable enrichment strategy that adds value to S. album leaves and supports their development as a safe, multi‐target phytopharmaceutical for diabetes management.
- 9 April 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (14)
Enrichment of Vitexin and Isovitexin From Santalum album L. Leaves and Evaluation of Their In Vitro and In Vivo Biological Activities
Vitexin and isovitexin are flavonoids with diverse pharmacological properties; however, their enrichment usually relies on chromatographic techniques, which are labor‐intensive and costly. This study reports, for the first time, a simple and chromatography‐free method to prepare a vitexin‐ and isovitexin‐enriched extract (VIEE) from Santalum album L. leaves. The method involved (i) biphasic partitioning between n‐hexane and water, followed by (ii) cold‐water recrystallization. UHPLC analysis confirmed that VIEE contained 456.038 mg/g vitexin and 221.422 mg/g isovitexin (67.75% total), corresponding to a 6.1‐fold increase compared with the hydroethanolic extract. Toxicological assessment demonstrated high safety, with LD 50 > 2.5 g/kg and no adverse effects in a 28‐day sub‐acute study at doses up to 900 mg/kg. Biologically, VIEE exhibited moderate inhibition of α‐glucosidase and α‐amylase , potent antioxidant activity in DPPH and ABTS assays, and acetylcholinesterase inhibition comparable to berberine. In streptozotocin‐induced diabetic mice, VIEE (300 mg/kg) lowered blood glucose by 43.2% after 14 days, prevented weight loss, and showed efficacy comparable to glibenclamide (47.9% reduction), while not affecting normoglycemic mice. Overall, this study introduces a cost‐effective, scalable enrichment strategy that adds value to S. album leaves and supports their development as a safe, multi‐target phytopharmaceutical for diabetes management.